We proudly like to announce, that we opened our first German subsidiary on the first of April 2020 in the western part of Germany. The new office is located in Siegburg (between Cologne and Bonn), which has an ideally infrastructure for travelling (ICE railway station nearby). Our Managing Director Petra Löhmer, has more than 25 years of clinical research experience. The new subsidiary enables small to midsize biotech and medical device companies of the western and southern part of Germany to have a closer contact to our clinical research experts. Petra is happy to discuss your potential new projects and collaboration interests.

News
Real-Time Clinical Trials: What the FDA’s New Initiative Means for Clinical Research
The FDA has announced an important step toward real-time clinical trials: two proof-of-concept trials are already underway, and a broader pilot program is planned for
